Heparin pretreatment in patients with ST-segment elevation myocardial infarction: A meta-analysis
Luca Franchin1, Federico Angriman2, Andrea Pezzato3
1Department of Cardiology, Santa Maria della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Summary
Administering heparin before treatment for ST-segment elevation myocardial infarction (STEMI) significantly reduces mortality and improves artery patency. This pretreatment strategy is safe and effective, showing no increase in major bleeding complications.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Coronary Syndromes
Background:
- Limited data exists on optimal heparin timing for ST-segment elevation myocardial infarction (STEMI).
- Heparin is crucial in STEMI management, but its administration timing (pretreatment vs. intraprocedural) is debated.
Purpose of the Study:
- To compare the prognostic impact of heparin pretreatment versus intraprocedural administration in STEMI patients.
- To evaluate the efficacy and safety of early heparin administration in STEMI.
Main Methods:
- Systematic literature search for studies from 1980-2024 comparing heparin pretreatment and intraprocedural administration in STEMI.
- Random-effect meta-analysis of clinical outcomes, including mortality, infarct-related artery patency, and bleeding complications.
Main Results:
- Analysis of 15 studies (11 observational, 4 trials) involving 72,249 patients.
- Heparin pretreatment significantly decreased 30-day mortality (OR=0.68) and long-term mortality (OR=0.67).
- Pretreatment increased infarct-related artery patency (OR=1.54) without a significant rise in major bleeding (OR=0.96).
Conclusions:
- Heparin pretreatment at STEMI diagnosis improves infarct-related artery patency and reduces mortality.
- This strategy offers a favorable risk-benefit profile, with no increased bleeding risk.
- Early heparin administration is recommended for STEMI management.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
903
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
903
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:28Acute Coronary Syndrome IV: Interprofessional Care
27
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
27
01:30Acute Coronary Syndrome I: Introduction
72
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
72
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44